- Home
- SQNS vs VNRX Comparison
SQNS vs VNRX Comparison
Compare SQNS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- VNRX
- Stock Information
- Founded
- SQNS 2003
- VNRX N/A
- Country
- SQNS France
- VNRX United States
- Employees
- SQNS N/A
- VNRX N/A
- Industry
- SQNS Semiconductors
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SQNS Technology
- VNRX Health Care
- Exchange
- SQNS Nasdaq
- VNRX Nasdaq
- Market Cap
- SQNS 46.5M
- VNRX 52.4M
- IPO Year
- SQNS 2011
- VNRX N/A
- Fundamental
- Price
- SQNS $1.43
- VNRX $0.78
- Analyst Decision
- SQNS Strong Buy
- VNRX Strong Buy
- Analyst Count
- SQNS 1
- VNRX 5
- Target Price
- SQNS $7.50
- VNRX $3.88
- AVG Volume (30 Days)
- SQNS 977.3K
- VNRX 316.6K
- Earning Date
- SQNS 08-22-2025
- VNRX 08-13-2025
- Dividend Yield
- SQNS N/A
- VNRX N/A
- EPS Growth
- SQNS N/A
- VNRX N/A
- EPS
- SQNS 2.16
- VNRX N/A
- Revenue
- SQNS $38,858,000.00
- VNRX $1,308,361.00
- Revenue This Year
- SQNS N/A
- VNRX $563.72
- Revenue Next Year
- SQNS $93.87
- VNRX $160.43
- P/E Ratio
- SQNS $0.68
- VNRX N/A
- Revenue Growth
- SQNS 40.06
- VNRX 64.16
- 52 Week Low
- SQNS $0.95
- VNRX $0.40
- 52 Week High
- SQNS $4.28
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- SQNS 37.63
- VNRX 58.50
- Support Level
- SQNS $1.26
- VNRX $0.71
- Resistance Level
- SQNS $2.33
- VNRX $0.92
- Average True Range (ATR)
- SQNS 0.20
- VNRX 0.11
- MACD
- SQNS -0.05
- VNRX 0.01
- Stochastic Oscillator
- SQNS 18.69
- VNRX 59.28
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.